To learn how we can continue to provide clarity to all your Oncology needs, please contact us.
[1] Kyuno et al., Tissue Barriers. 10(1), Jan 2022
[2] ASCO GI, Abs LBA292, Jan 19 2023
[3] ASCO Plenary Series, Abs 405736, Mar 22 2023
[4] Astellas Press Release, Mar 22 2023
[5] Janjigian et al., Lancet, 398, Jul 2021
Copyright © 2023 Oracle and/or its affiliates. All rights reserved.
2934773625_Cerner Enviza Oncology Insights: Targeting Claudin18 whitepaper_May23 v1